CORRECTION: Diagnostic Hybrids Corrects Statement on FDA H1N1 Test Claims | GenomeWeb

This artcile has been updated following a correction issued by Diagnostic Hybrids on Sep. 2.

NEW YORK (GenomeWeb News) – Diagnostic Hybrids on Wednesday issued a correction to an earlier statement and said that the US Food and Drug Administration has not cleared any additional claims or new intended uses for its respiratory virus test kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.